AME

Business profile & competitive position

AMETEK, Inc. is classified in the Industrials sector, specifically the Electrical Equipment & Parts industry. At its core, the company is a global manufacturer of electronic instruments and electromechanical devices, organized through two operating groups. Electronic Instruments, or EIG, designs and manufactures advanced analytical, test and measurement instruments for the process, aerospace, power and industrial markets. The Electromechanical Group, or EMG, supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and other industrial markets. This dual-segment structure positions AMETEK as both a precision-component supplier and an analytical-instrument provider, with end markets that span from factory floors to surgical suites.

The company's financial footprint supports the view that it operates with meaningful pricing discipline and capital efficiency. For 2025, AMETEK reported sales of $7,401.1 million, up 6.6% from 2024, and diluted earnings per share of $6.40, up 7.9%. Net margin sits at 20.0%, and return on equity is 14.5%. In manufacturing, a 20% net margin is generally well above the industrial median, while a mid-teens ROE signals that management is converting shareholder equity into earnings at an above-average clip. These figures are consistent with a business that emphasizes specialized, hard-to-replicate components, long-term customer relationships, and continuous cost programs such as Design for Six Sigma and value engineering.

Financial posture

AMETEK carries a market capitalization of $57.7 billion and trades at a P/E of 36.7. By industrial-equipment standards, that multiple is elevated and implies the market is pricing in sustained earnings growth rather than viewing the company as a mature cyclical. The 20.0% net margin and 14.5% ROE help justify quality status, but the valuation alone narrows the margin of safety for buyers at current levels.

The stock's beta is 0.99, meaning its systematic risk is essentially in line with the broad market. That is slightly unusual for an industrials name with aerospace exposure and can be read as a sign of stable, non-speculative cash-flow visibility. On the balance sheet, growth has not been organic alone: in 2025, AMETEK deployed $933.2 million in cash, net of cash acquired, to buy Kern and FARO Technologies, adding high-precision machining, optical inspection and 3D measurement capabilities. From 2021 through December 31, 2025, the company completed 15 acquisitions representing approximately $1.8 billion in annualized sales. That acquisition cadence is central to the company's financial posture: investors are not just underwriting current operations but management's ability to keep buying and integrating complementary assets profitably.

Strategic priorities & outlook

AMETEK's most recent 10-K frames the company's near-term playbook around the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. The model is intentionally multidimensional: it is not enough to grow the top line; acquisitions and operations must also convert into per-share earnings and capital returns.

Operational Excellence is the second pillar, with the filing listing lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, digitalization and artificial intelligence. These are the mechanisms by which AMETEK tries to defend its 20.0% net margin in an environment of wage, energy and logistics pressures.

Strategic M&A remains the third pillar. The company pursues deals with compelling strategic, technical and cultural fit in adjacent or complementary markets aligned with secular growth themes. The 2025 deals for Kern and FARO fit that template, extending precision measurement and inspection expertise.

Finally, global expansion is a stated priority, with best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia. The filing notes that 52% of EIG's net sales and 42% of EMG's net sales were to customers outside the United States in 2025. As of December 31, 2025, AMETEK employed approximately 22,500 people. For investors, the takeaway is that the growth strategy is global, acquisitive and margin-focused in equal measure.

Macro & geopolitical exposure

Because AMETEK sits in the Electrical Equipment & Parts industry, its macro exposure is a blend of industrial demand, trade policy, currency and supply-chain inputs. Electrical components and precision electromechanical devices are exposed to industrial-capital spending cycles: when aerospace, automation, power, and medical equipment customers pull back on capex, order flow can soften. The sector is also affected by raw-material and energy costs, including specialty metals used in interconnects and thermal-management systems.

Trade and tariff risk is meaningful here. With almost half of segment sales going outside the U.S. and best-cost manufacturing facilities spread across China, Czechia, Malaysia, Mexico and Serbia, AMETEK is directly exposed to cross-border tariff policy, export controls and localization requirements. Medical, aerospace and defense customers often carry regulatory approval processes that can delay product qualifications during supply-chain changes. Semiconductor and electronic-component shortages, while less acute than in prior years, can also interrupt finished-goods output. Finally, currency translation matters: a stronger dollar can compress the value of non-U.S. revenue when converted back to U.S. dollars.

Recent developments

Recent headlines have focused on both valuation and near-term momentum. On October 5, 2026, zacks.com published "Ametek (AME) Is Up 0.47% in One Week: What You Should Know," framing a modest positive price move. Five days earlier, on October 1, 2026, zacks.com also reported a rating upgrade to "Buy" in "All You Need to Know About Ametek (AME) Rating Upgrade to Buy." The reason given is consistent with the broader analyst narrative around durable earnings quality and aerospace exposure.

Earlier in September, on September 17, 2026, fool.com tied AMETEK to the NASA Moon Base contract under the headline "NASA's New Moon Base Contract Could Be an Out-of-This-World Opportunity for This Under-the-Radar Nuclear Power Stock." That story highlights the company's aerospace and nuclear-related instrumentation as a potential long-cycle growth driver. On the other side of the valuation debate, gurufocus.com published "Is AME Overvalued? DCF Says Worth $158" on September 16, 2026. That headline introduces a valuation anchor well below the current price and shows that not all quant-driven commentary agrees with the bullish sell-side momentum. We do not validate either view here, but the contrast is useful context.

Earnings behavior & post-earnings drift

AMETEK reports next on October 29, 2026, before the market opens, with a consensus EPS estimate of $2.10. Historically, the company has delivered reliable beats. Over the last eight reported quarters, AMETEK beat analyst estimates all eight times, for a 100% beat rate. The average earnings surprise across those quarters was 4%.

Yet beating estimates has not reliably pushed the share price higher. The average 5-day price move in the five trading days after earnings across those same eight quarters is 0.46%, which the data classifies as a "flat" drift. In other words, the market's real expectation appears to be priced in ahead of the report, leaving little directional follow-through even when results exceed published estimates.

The most recent four quarters illustrate that pattern in detail. On August 4, 2026, AMETEK reported EPS of $2.09 against an estimate of $1.99, a 5% surprise, but the stock rose just 0.28% the next day and 0.89% over the following five days. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the stock fell 2.13% the next session and was down 0.33% over the next five days. The February 3, 2026 report saw EPS of $2.01 versus $1.94, a 3.6% surprise, with the stock dropping 0.48% the next day but then rising 1.83% over the next five days. The October 30, 2025 quarter produced the largest surprise, $1.89 versus $1.76, or 7.4%; the stock jumped 1.91% the next day but gave back 0.54% over the next five days. Collectively, these results show that the post-earnings window has been a coin-flip on direction even when the absolute earnings result is strong.

At the current snapshot, AMETEK trades at $251.92, with an RSI of 62.2 and a 50-day EMA of $242.56. The price sits above its 50-day average, reflecting the recent positive momentum referenced in the early-October headlines, while the RSI is elevated but not technically overbought.

For a fuller picture of how institutional analysts are modeling revenue by segment, free-cash-flow conversion and the next several quarters, readers should consult the full institutional verdict and cross-reference the consensus framework before forming their own view.